Kidney health Drugs: Medicare Part D Spending

What Medicare Part D spent on the medicines used for this topic, how many people used them, and the cost per unit.

Each number has its full source under its own list below.

Medicare Part D spending

42 medicines (calendar year 2024). Medicines whose FDA label lists a use on this topic, by what Part D spent on them in total. Many medicines have more than one use, so the totals are not added up.

At the source
  1. 1FarxigaDapagliflozin Propanediol · $18.31 per unit$5.3 billion
  2. 2Potassium Chloride*Potassium Chloride · $0.24 per unit$290.9 million
  3. 3DapagliflozinDapagliflozin Propanediol · $16.24 per unit$201.9 million
  4. 4Sevelamer CarbonateSevelamer Carbonate · $0.84 per unit$141.9 million
  5. 5Furosemide*Furosemide · $0.08 per unit$118.9 million
  6. 6Cinacalcet HClCinacalcet HCl · $5.56 per unit$84.7 million
  7. 7Bumetanide*Bumetanide · $0.43 per unit$78.6 million
  8. 8TorsemideTorsemide · $0.22 per unit$54.5 million
  9. 9Potassium Citrate ERPotassium Citrate · $0.61 per unit$49.9 million
  10. 10RenvelaSevelamer Carbonate · $6.39 per unit$38 million
  11. 11Calcium AcetateCalcium Acetate · $0.30 per unit$27.6 million
  12. 12FuroscixFurosemide · $896.08 per unit$27.2 million
  13. 13Sevelamer HClSevelamer HCl · $3.49 per unit$23.6 million
  14. 14AzathioprineAzathioprine · $0.48 per unit$19.7 million
  15. 15Klor-Con M20Potassium Chloride · $0.19 per unit$15.4 million

Source: Centers for Medicare & Medicaid Services, Medicare Part D Spending by Drug, calendar year 2024. Retrieved 12 Nov 2026.

Benchmarks on kidney health

Countries side by side on public measures for this topic.

All benchmarks

Acuitas market sizes and forecasts are only in our full reports. How we use public data.